Upload
kenny-treese
View
221
Download
1
Tags:
Embed Size (px)
Citation preview
DRUG ALLERGY TO ANTIBIOTICS: DRUG ALLERGY TO ANTIBIOTICS: GENERAL REVIEWGENERAL REVIEW
Ricardo Cardona Villa, Ricardo Cardona Villa, M.D.M.D.
MSc in Immunology - AllergistMSc in Immunology - Allergist
Chief of Clinical Allergology ServiceChief of Clinical Allergology Service
IPS Universitaria - Clínica León XIIIIPS Universitaria - Clínica León XIII
Medical School Medical School
Universidad de AntioquiaUniversidad de Antioquia
Carder K.R. Hypersensitivity reactions in neonates and infants. Dermatologic Therapy, Vol. 18, 2005, 160–175
Urticarial plaques Urticarial plaques associated with associated with
cephalexincephalexin
Photograph courtesy of Peter Friedmann, University
of Southampton, United Kingdom.
Rebecca S. Gruchalla R.B and Pirmohamed M. Antibiotic Allergy. N Engl J Med 2006;354:601-9.
Urticaria associated with Urticaria associated with ampicillin allergyampicillin allergy
Photograph courtesy of Peter Friedmann, Universityof Southampton, United Kingdom.
Rebecca S. Gruchalla R.B and Pirmohamed M. Antibiotic Allergy. N Engl J Med 2006;354:601-9.
Maculopapular rash Maculopapular rash associated with associated with
flucloxacillin allergyflucloxacillin allergy
McKenna J.K. and Leiferman, K.M. Dermatologic drug reactions. Immunol Allergy Clin N Am 24 (2004) 399– 423
Exanthematous Exanthematous drug eruption drug eruption
caused by caused by amoxicillinamoxicillin
McKenna J.K. and Leiferman, K.M. Dermatologic drug reactions. Immunol Allergy Clin N Am 24 (2004) 399– 423
Acute generalized exanthematous pustulosis
from amoxicillin
McKenna J.K. and Leiferman, K.M. Dermatologic drug reactions. Immunol Allergy Clin N Am 24 (2004) 399– 423
Leukocytoclastic vasculitis
McKenna J.K. and Leiferman, K.M. Dermatologic drug reactions. Immunol Allergy Clin N Am 24 (2004) 399– 423
Toxic epidermal necrolysisToxic epidermal necrolysis
Allergic contact dermatitis Allergic contact dermatitis to topical antibioticsto topical antibiotics
Kathryn A. Gehrig k.A. and Warshaw E.M. Allergic contact dermatitis to topical antibiotics: Epidemiology, responsible allergens, and management. J Am Acad Dermatol 2008;58:1-21.
Type A reactions
Type B reactions that are uncommonType B reactions that are uncommon (approximately 10% to 15%), not predictable, and occur only in susceptible individuals
Others: type C and type D reactions. Rawlins M, Thompson W. Mechanisms of adverse drug reactions. In: Davies D, editor. Textbook of adverse drug reactions. New York: Oxford Press; 1991. p. 18–45.Schnyder B. Approach to the Patient with Drug Allergy. Immunol Allergy Clin N Am 29 (2009) 405–418
ADRs have been classified byADRs have been classified byRawlins and Thompson in four types:Rawlins and Thompson in four types:
Allergic reactions are, by definition, immunologically mediated.immunologically mediated.
A single drug may initiate multiple immune responses, and multiple antigenic determinants
may be formed from a single drug.
Park BK, Pirmohamed M, Kitteringham NR. Role of drug disposition in drug hypersensitivity: a chemical, molecular, and clinical perspective. Chem Res Toxicol 1998;11:969-88.
Schnyder B, Mauri-Hellweg D, Zanni M, Bettens F, Pichler WJ. Direct, MHCdependent presentation of the drug sulfamethoxazole to human alpha/beta T cell clones. J Clin Invest 1997;100:136-41.
Pathogenic FeaturesPathogenic Features
The reaction is not an expectedis not an expected pharmacologic effect.
Demoly Pascal. Classification and Epidemiology of hipersensitivity drug reactions.
Immunology Allergy Clin N Am. 24(2004) 345-356.
Several criteria characterize Several criteria characterize an allergic reactionan allergic reaction
The reaction is not an expectedis not an expected pharmacologic effect.
A period of sensitization precedessensitization precedes the reaction.
Demoly Pascal. Classification and Epidemiology of hipersensitivity drug reactions.
Immunology Allergy Clin N Am. 24(2004) 345-356.
Several criteria characterize Several criteria characterize an allergic reactionan allergic reaction
The reaction is not an expectedis not an expected pharmacologic effect.
A period of sensitization precedessensitization precedes the reaction.
The reaction may occur at a dose much lowerdose much lower than that required for a pharmacologic effect.
Demoly Pascal. Classification and Epidemiology of hipersensitivity drug reactions.
Immunology Allergy Clin N Am. 24(2004) 345-356.
Several criteria characterize Several criteria characterize an allergic reactionan allergic reaction
Demoly Pascal. Classification and Epidemiology of hipersensitivity drug reactions.
Immunology Allergy Clin N Am. 24(2004) 345-356.
The clinical symptoms are characteristic of an are characteristic of an allergic reactionallergic reaction
Several criteria characterize Several criteria characterize an allergic reactionan allergic reaction
Resolution occurs within an expected interval,within an expected interval, usually days, after discontinuation of the offending agent
Demoly Pascal. Classification and Epidemiology of hipersensitivity drug reactions.
Immunology Allergy Clin N Am. 24(2004) 345-356.
The clinical symptoms are characteristic of anare characteristic of an allergic reactionallergic reaction
Several criteria characterize Several criteria characterize an allergic reactionan allergic reaction
Resolution occurs within an expected interval,within an expected interval, usually days, after discontinuation of the
offending agent
Chemical cross-reactivity may occurmay occur
Classification ofClassification ofallergic reactions to drugsallergic reactions to drugs
Gell and Coombs classification (1960):
The physiological The physiological mechanismsmechanisms
(Gell P. and Coombs R. Clinical aspects of immunology Blalckwell Scient Publ Oxford; 1964).
(Coombs PRA, Gell PGH. Classification of allergic reactions responsible for clinical hypersensitivity and disease. In: Gell RRA, editor.
Clinical aspects of immunology. Oxford: Oxford University Press; 1968. p. 575–96.)
Levine classification (1966):
The time taken for The time taken for symptoms to appearsymptoms to appearImmediately: Less than an hour
Fast: 6-48 hours later.
Delayed: After 48 hours.
(Immunologic mechanisms of penicillin allergy. A haptenic model system for the study of allergic diseasess of man. NEJM 1966; 275: 1115-25)
http://www.monografias.com/trabajos59/fabula-lanzador-redes/Image23883.gif
Is a fishing net adequate for our purposes ?Is a fishing net adequate for our purposes ?
My personal opinion is that, My personal opinion is that,
like our fisherman here like our fisherman here
Our fishing net is
not big enough to
catch all drug
allergies
My personal opinion is that, My personal opinion is that,
like our fisherman herelike our fisherman here
AND
Our fishing net allows
too many of them to
escape
We need to discover new knowledge or create a
new system that captures everything.
OR MAYBE...OR MAYBE...
Middleton’s. allergy: Principles and Practices. Seventh edition. 2009
Multivalency theory Multivalency theory of haptenic drug allergyof haptenic drug allergy
Gerber B.O. And and Pichler W.J. Cellular mechanisms of T cell mediated drug hypersensitivity. Current Opinion in Immunology 2004, 16:732–737
A schematic comparison A schematic comparison of the p-i concept with the hapten modelof the p-i concept with the hapten model
The World Allergy Organization has recommended the use of the adjectives immediateimmediate and delayeddelayed
referring to the onset of the symptoms,
as helpful in distinguishing whether the probable immunologic mechanism is antibody mediated or
T-lymphocyte-mediated.
Johansson S.G., Bieber T., Dahl R., et al: Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization October 2003. J Allergy Clin Immunol 2004; 113:832-836.
Gell and Coombs classification Gell and Coombs classification
Ricardo Cardona V. y Carlos Serrano ,Alergia: Abordaje Clínico, Diagnóstico y Tratamiento. Cap. 1, Aspectos Básicos de la Alergia y Reacciones de Hipersensibilidad. Ed. Panamericana (en prensa)
Werner J. Pichler, MD Immune mechanism of drug hypersensitivity Immunol Allergy Clin N Am 24 (2004) 373–397
Schematic representation of overlapping Schematic representation of overlapping immune functionsimmune functions
Pichler, W.J. Immune mechanism of drug hypersensitivity. Immunol Allergy Clin N Am 24 (2004) 373– 397
Revised Gell and Coombs classification Revised Gell and Coombs classification of drug reactionsof drug reactions
Scheme adapted from Janeway CA, Travers P, Walport M, Shlochik M. Immunobiology. New York: Garland Publishing; 2001
Th17Th 9
T Cell T Reg
Th2
Th1
Th17
Th9
Th1Th1
Th2Th2
Th9Th9
Th17Th17
TregTreg
TT
Cell TCell T
type IVa
macrophage
type IVd
neutrophils
type IVb
eosinophils
INF INF γγ, TNF, TNFαα
(Th1 cells)(Th1 cells)
CXCL 8, GM-SCFCXCL 8, GM-SCF
(T cell)(T cell)
Perforin/Granzyme B Perforin/Granzyme B (CTL)(CTL)
IL 5, IL4/IL13 IL 5, IL4/IL13
(Th2 cells)(Th2 cells)
type IVc
CD4 and CD8
Cytotoxic T cell
Th1Th1
Th2Th2
Th9Th9
Th17Th17
TregTreg
TT
Cell TCell T
type IVa
macrophage
type IVd
neutrophils
type IVb
eosinophils
type I
type IVb
eosinophils
cell B
INF INF γγ, TNF, TNFαα
(Th1 cells)(Th1 cells)
CXCL 8, GM-SCFCXCL 8, GM-SCF
(T cell)(T cell)
Perforin/Granzyme B Perforin/Granzyme B (CTL)(CTL)
IL 5, IL4/IL13 IL 5, IL4/IL13
(Th2 cells)(Th2 cells)
IL 5, IL4/IL13
type IVc
CD4 and CD8
Cytotoxic T cell
Th1Th1
Th2Th2
Th9Th9
Th17Th17
TregTreg
TT
Cell TCell T
IgE
Th1Th1
Th2Th2
Th9Th9
Th17Th17
TregTreg
TT
Cell TCell T
IgE
type IVa
macrophage
type IVd
neutrophils
type IVb
eosinophils
type IVa
macrophage
type II
type III
cell B
type I
type IVb
eosinophils
cell B
C, O2
IgG
IgG
INF INF γγ, TNF, TNFαα
(Th1 cells)(Th1 cells)
CXCL 8, GM-SCFCXCL 8, GM-SCF
(T cell)(T cell)
Perforin/Granzyme B Perforin/Granzyme B (CTL)(CTL)
IL 5, IL4/IL13 IL 5, IL4/IL13
(Th2 cells)(Th2 cells)
IL 5, IL4/IL13
type IVc
CD4 and CD8
Cytotoxic T cell
Th1Th1
Th2Th2
Th9Th9
Th17Th17
TregTreg
TT
Cell TCell T
IgE
IL 17
type IVa
macrophage
type IVd
neutrophils
type IVb
eosinophils
type IVa
macrophage
type II
type III
cell B
type I
type IVb
eosinophils
type IVd
neutrophilscell B
C, O2
IgG
IgG
INF INF γγ, TNF, TNFαα
(Th1 cells)(Th1 cells)
CXCL 8, GM-SCFCXCL 8, GM-SCF
(T cell)(T cell)
Perforin/Granzyme B Perforin/Granzyme B (CTL)(CTL)
IL 5, IL4/IL13 IL 5, IL4/IL13
(Th2 cells)(Th2 cells)
IL 5, IL4/IL13
type IVc
CD4 and CD8
Cytotoxic T cell
Th1Th1
Th2Th2
Th9Th9
Th17Th17
TregTreg
TT
Cell TCell TIL 17
IgE
type IVa
macrophage
type IVd
neutrophils
type IVb
eosinophils
type IVa
macrophage
type II
type III
cell B
type I
type IVb
eosinophils
type IVd
neutrophils
Pre Th
cell B
C, O2
IgG
IgG
Th1
Th2
INF INF γγ, TNF, TNFαα
(Th1 cells)(Th1 cells)
CXCL 8, GM-SCFCXCL 8, GM-SCF
(T cell)(T cell)
Perforin/Granzyme B Perforin/Granzyme B (CTL)(CTL)
IL 10, TGF β
IL 12 β
IL 5, IL4/IL13 IL 5, IL4/IL13
(Th2 cells)(Th2 cells)
IL 5, IL4/IL13
type IVc
CD4 and CD8
Cytotoxic T cell
Th1Th1
Th2Th2
Th9Th9
Th17Th17
TregTreg
TT
Cell TCell T
IgE
?
IL 17
type IVa
macrophage
type IVd
neutrophils
type IVb
eosinophils
type IVa
macrophage
type II
type III
cell B
type I
type IVb
eosinophilstype IVb
eosinophils
type IVd
neutrophils
Pre Th
cell B
C, O2
IgG
IgG
Th1
Th2
INF INF γγ, TNF, TNFαα
(Th1 cells)(Th1 cells)
CXCL 8, GM-SCFCXCL 8, GM-SCF
(T cell)(T cell)
Perforin/Granzyme B Perforin/Granzyme B (CTL)(CTL)
IL 10, TGF β
IL 12 β
IL 5, IL4/IL13 IL 5, IL4/IL13
(Th2 cells)(Th2 cells)
IL 5, IL4/IL13
type IVc
CD4 and CD8
Cytotoxic T cell
Th1Th1
Th2Th2
Th9Th9
Th17Th17
TregTreg
TT
Cell TCell T
IgE
?
IL 17
type IVa
macrophage
type IVd
neutrophils
type IVb
eosinophils
type IVa
macrophage
type II
type III
cell B
type I
type IVb
eosinophilstype IVb
eosinophils
type IVd
neutrophils
Pre Th
cell B
C, O2
IgG
IgG
Th1
Th2
INF INF γγ, TNF, TNFαα
(Th1 cells)(Th1 cells)
CXCL 8, GM-SCFCXCL 8, GM-SCF
(T cell)(T cell)
Perforin/Granzyme B Perforin/Granzyme B (CTL)(CTL)
IL 10, TGF β
IL 12 β
IL 5, IL4/IL13 IL 5, IL4/IL13
(Th2 cells)(Th2 cells)
IL 5, IL4/IL13
type IVc
CD4 and CD8
Cytotoxic T cell
The mechanisms The mechanisms underlyingunderlying
antibiotic allergyantibiotic allergy have have not been clearly not been clearly
elucidatedelucidated..
..Some people believe that ..Some people believe that everything they see is true; everything they see is true;
like “the world is flat”...like “the world is flat”...
Areas of UncertaintyAreas of Uncertainty
Indications for ‘skin prick test’ Indications for ‘skin prick test’ and ‘intradermal test’and ‘intradermal test’
Erythematous eruption/flushing
Bronchospasm/asthma
Conjunctivitis
Anaphylaxis
Angioedema
Urticaria
Rhinitis
Kranke B.and Aberer W. Skin testing for IgE-mediated drug allergy. Immunol Allergy Clin N Am 2009;29:503-516
No indications for ‘skin prick test’ No indications for ‘skin prick test’ and ‘intradermal test’and ‘intradermal test’
Drug-induced autoimmune diseases:Drug-induced autoimmune diseases:
Bullous pemphigoid, Pemphigus vulgaris, Systemic lupus erythematosus.
Kranke B.and Aberer W. Skin testing for IgE-mediated drug allergy. Immunol Allergy Clin N Am 2009;29:503-516
No indications for ‘skin prick test’ No indications for ‘skin prick test’ and ‘intradermal test’and ‘intradermal test’
Drug-induced autoimmune diseases:Drug-induced autoimmune diseases:
Bullous pemphigoid, Pemphigus vulgaris, Systemic lupus erythematosus.
Severe vasculitis syndromesSevere vasculitis syndromes
Kranke B.and Aberer W. Skin testing for IgE-mediated drug allergy. Immunol Allergy Clin N Am 2009;29:503-516
No indications for ‘skin prick test’ No indications for ‘skin prick test’ and ‘intradermal test’and ‘intradermal test’
Severe exfoliative skin reactions:Severe exfoliative skin reactions:
Acute generalized exanthematic pustulosis, drug reaction with eosinophilia and systemic symptoms or drug hypersensitivity syndrome, exfoliative dermatitis,
multilocalized bullous fixed drug eruption, Stevens-Johnson syndrome, toxic epidermal necrolysis.
Kranke B.and Aberer W. Skin testing for IgE-mediated drug allergy. Immunol Allergy Clin N Am 2009;29:503-516
SPT and IDT with the major and minor SPT and IDT with the major and minor determinates of determinates of penicillinpenicillin
Kranke B.and Aberer W. Skin testing for IgE-mediated drug allergy. Immunol Allergy Clin N Am 2009;29:503-516
Medical history taking is
critical in the evaluationevaluation of
antibiotic allergy and
in distinguishingdistinguishing
allergic reactions from other
adverse reactions
Rebecca S. Gruchalla R.B and Pirmohamed M. Antibiotic Allergy. N Engl J Med 2006;354:601-9.
Clinical assessmentClinical assessment
Ancient Greek painting in a vase, showing a physician (iatros) bleeding a patient
Skin Testing:Skin Testing:
Skin testing is the basic diagnostic toolthe basic diagnostic tool, although in patients with a history of severe reactions, in vitro
tests may be the recommended choice.
Diagnosis testsDiagnosis tests
Blanca M., Romano A., Torres M.J., Fernández J, et al. Update on the evaluation of hypersensitivity reactions to betalactams. Allergy 2009. 64, 183-193
Skin testing is highly accurate for the identification
of penicillin allergy.of penicillin allergy.
Other Testing:Other Testing:
The measurement of IL-2, IL-5, IL-13 or IFN-gammaIL-2, IL-5, IL-13 or IFN-gamma or a combination there of might be a useful in vitro tool for detection of T-cell sensitization to drugs
Lochmatter P., Beeler A., Kawabata T.T., Gerber B.O., Pichler W. J. Drug-specific in vitro release of IL-2, IL-5, IL-13 and IFN-gamma in patients with delayed-type drug hypersensitivity . Allergy 2009: 64: 1269–1278
Diagnosis testsDiagnosis tests
Hausmann O.V et al. The basophil activation test in immediate-type drug allergy. Immunol Allergy Clin N Am 29 (2009) 555–566
The basophil activation test as a funtional a funtional in vitro in vitro testtest
in immediate-type drug allergy.
Other Testing:Other Testing:
Drug-specific T cells, which are involved in some hypersensitivity reactions, may be detected with the use of in vitro lymphocyte transformation testslymphocyte transformation tests
Diagnosis testsDiagnosis tests
Blanca M., Romano A., Torres M.J., Fernández J, et al. Update on the evaluation of hypersensitivity reactions to betalactams. Allergy 2009. 64, 183-193
Bernstein I.L., James T., Li J.T., Bernstein D.I.,Hamilton R., et al, Allergy Diagnostic Testing: An Updated Practice Parameter. ANNALS OF ALLERGY, ASTHMA & IMMUNOLOGY. VOLUME 100, MARCH, 2008: S1-S148
Other Testing:Other Testing:
Drug provocation test.Drug provocation test. The ENDA document stated that the DPT was, at that time, the best tool to to confirmconfirm a causal relationship between drug administration and non-immediate adverse reactions.
Diagnosis testsDiagnosis tests
Romano A, Blanca M, Torres MJ, Bircher A, et al. Diagnosis of nonimmediate reactions to beta-lactam antibiotics. Allergy 2004;59:1153-1160.
Blanca M., Romano A., Torres M.J., Fernández J, et al. Update on the evaluation of hypersensitivity reactions to betalactams. Allergy 2009. 64, 183-193
Clinical History of reaction
Delayed (> 1 hour)
(Urticaria, AE, rash)
Skin test(*)
Specific IgE (CAP)
Any Positive Both negative
Late with intradermal or
epicutaneous with drug envolved
Negative
Immediate (< 1hour)
(urticaria, AE, Anaphylaxis)
Positive
PEC(**)AllergyPEC(**)Allergy
Negative
Positive
Positive
Reaction
Negative
Tolerance
Allergy
Allergy
Skin test +
PEC (**)(^^)
Yes
Reaction over two
Years ago
No
No Allergy Allergy
No AllergyAllergy
Both NegativeAny positive
Complete curse of
the treatment
Cardona R, Serrano C, Alergia: Abordaje Clínico, Diagnóstico y Tratamiento.Cap. 58, Alergia a betalactaminos. Ed. Panamericana (In Press)
No Allergy
Delayed (> 1 hour)
(Urticaria, AE, rash)
Skin test(*)
Specific IgE (CAP)
Any Positive Both negative
Late with intradermal or
epicutaneous with drug envolved
Negative
Immediate (< 1hour)
(urticaria, AE, Anaphylaxis)
Positive
PEC(**)AllergyPEC(**)Allergy
Negative
Positive
Positive
Reaction
Negative
Tolerance
Allergy
Allergy
Skin test +
PEC (**)(^^)
Yes
Reaction over two
Years ago
No
No Allergy Allergy
No AllergyAllergy
Both NegativeAny positive
Complete curse of
the treatment
Cardona R, Serrano C, Alergia: Abordaje Clínico, Diagnóstico y Tratamiento.Cap. 58, Alergia a betalactaminos. Ed. Panamericana (In Press)
No Allergy
Clinical History of reaction
Volcheck G.W. Clinical evaluation and manegement of drug hypersensitivity.Immunol Allergy Clin N Am 24(2004) 357-371
Identification Identification and futureand future
management ofmanagement of the most common the most common
drug reactionsdrug reactions
Aberer W. And Kranke B. ProvocationTests in Drug Hypersensitivity. Immunol Allergy Clin N Am 29 (2009) 567–584
Autoimmune diseases:Autoimmune diseases:Bullous pemphigoid, Pemphigus vulgaris,
Systemic lupus erythematosus
Drug Provocation Test: Drug Provocation Test: ContraindicationsContraindications
Severe exfoliative skin reactions:Severe exfoliative skin reactions: AGEP, DRESS/Drug-induced hypersensitivity
syndrome, Exfoliative dermatitis, SJS, Toxic epidermal necrolysis
Aberer W. And Kranke B. ProvocationTests in Drug Hypersensitivity. Immunol Allergy Clin N Am 29 (2009) 567–584
Severe vasculitis syndromeSevere vasculitis syndrome
Drug Provocation Test: Contraindications
Specific organ manifestations:Specific organ manifestations:Blood cytopenia, hepatitis, nephritis,
pneumonitis
Midlleton´s Allergy Principles and practice 7 edition. Werner J Pichler, Andreas Beeler. Pharmacological Interaction of Drugs
with Immune Receptors: The p-I Concept Allergology International Vol 55, No1, 2006
Culprit drugCulprit drug DiseaseDisease HLAHLA EthnicityEthnicity
Carbamazepine SJS/TEN HLA-B 1502 Han-Chinese
Allopurinol SJS/TEN/HSS HLA-B 5801 Han-Chinese
Abacavir HSS HLA-B 5701 Caucasians
Genetic susceptibility toGenetic susceptibility to drug hypersensitivity drug hypersensitivity
“Drug allergy and
hypersensitivity have been recognized for decades,
but there are still large gapslarge gaps in our knowledge”
Bousquet P-J., Demoly P. & Romano A. Drug allergy and hypersensitivity: still a hot topic. Allergy 2009: 64: 179–182
Summary
Thanks !!Thanks !!